Daily Archives: August 1, 2018

CORRECTION FROM SOURCE: Transport Canada Certifies 90-Seat Cabin Configuration for Bombardier’s Q400 Aircraft

Launch customer SpiceJet of India to become first airline to take advantage of the extra-capacity turboprop’s increased profitability potential TORONTO, Aug. 01, 2018 (GLOBE NEWSWIRE) — This document corrects and replaces the press release that was sent today at 9:00… Read More

Williams Scotsman to Announce Second Quarter 2018 Results on August 7, 2018

BALTIMORE, Aug. 01, 2018 (GLOBE NEWSWIRE) — WillScot Corporation (Nasdaq: WSC) (“Williams Scotsman”) today announced that it will release its second quarter 2018 financial results Tuesday, August 7, 2018 after the markets close. President and Chief Executive Officer, Brad Soultz,… Read More

CORRECTING and REPLACING — Neuralstem, Inc.

GERMANTOWN, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) — In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke,” rather than, “Neuralstem Announces… Read More

Luxury Brand House of Sillage Launches Limited-Edition Lipstick Case & Refill With Diamond Powder

Also Wins Award for Product Innovation, Luxury Item at the ICMAD City Awards NEWPORT BEACH, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) — House of Sillage a leader in luxury haute parfumerie, is excited to announce its expansion into cosmetics with… Read More

Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke

GERMANTOWN, Md., July 31, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today announced the initiation of a Phase 2 clinical trial evaluating… Read More

Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke

GERMANTOWN, Md., July 31, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today announced the initiation of a Phase 2 clinical trial evaluating… Read More

WillScot Announces Pricing of $300 Million Senior Secured Notes Offering

BALTIMORE, July 31, 2018 (GLOBE NEWSWIRE) — WillScot Corporation (Nasdaq:WSC) (“WillScot”), a specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that its indirect subsidiary Mason Finance Sub, Inc. (“Issuer) has… Read More